| Related Articles |
In vitro activity of ceftazidime-avibactam against contemporary Pseudomonas aeruginosa isolates from United States medical centers by Census region (2014).
Antimicrob Agents Chemother. 2016 Jan 25;
Authors: Huband MD, Castanheira M, Flamm RK, Farrell DJ, Jones RN, Sader HS
Abstract
The in vitro antibacterial activity of ceftazidime-avibactam and comparator agents was evaluated by reference broth microdilution methods against a collection of 1,743 Pseudomonas aeruginosa isolates collected from sixty-nine medical centers in the United States during 2014 representing each of the nine Census regions. Ceftazidime-avibactam demonstrated potent activity against P. aeruginosa, including many isolates non-susceptible to ceftazidime, meropenem, and piperacillin-tazobactam. In each of the nine Census regions, ceftazidime-avibactam demonstrated the highest percentage of susceptible isolates.
PMID: 26810650 [PubMed - as supplied by publisher]